Assessment of phospholipid content in blood leukocytes of parturient women who had COVID-19 during the third trimester of pregnancy
https://doi.org/10.36604/1998-5029-2025-98-139-143
Abstract
Aim. To assess the content of phospholipids in leukocytes of peripheral blood in parturient women who had COVID-19 during the third trimester of pregnancy.
Materials and methods. The amount of the cytochemical reaction product for phospholipids in leukocytes of peripheral blood was determined using the reagent kit "DIAHIM-CYTOSTEINSCh" (Russia) in 102 parturient women. The first group included patients with mild course of COVID-19 (n = 34), the second group — patients with moderate course of COVID-19 (n = 32). The control group consisted of 36 women not infected with SARS-CoV-2.
Results. The phospholipid content in leukocytes of pregnant women who had COVID-19 differed significantly compared to the control group. In the control group, the mean cytochemical coefficient (MCC) was 2.67 ± 0.05 arbitrary units. In patients with COVID-19, a significant decrease in MCC was observed: in persons with a mild course of the disease to 2.42 ± 0.05 (p < 0.001), and in persons with a moderate course to 1.98 ± 0.04 arbitrary units (p < 0.001).
Conclusion. The data obtained suggest that COVID-19 infection affects the phospholipid content in the leukocytes of parturient women, reducing their amount. Further investigation of this issue may provide a detailed explanation of the impact of COVID-19 infection on pregnancy course and perinatal outcomes.
About the Authors
O. L. KutepovaRussian Federation
Olʹga L. Kutepova, PhD (Biol.), Staff Scientist, Laboratory of Molecular and Translational Research
22 Kalinina Str., Blagoveshchensk, 675000
I. A. Andrievskaya
Russian Federation
Irina A. Andrievskaya, PhD, DSc (Biol.), Professor of RAS, Head of Laboratory of Mechanisms of Etiopathogenesis and Recovery Processes of the Respiratory System at Non-Specific Lung Diseases
22 Kalinina Str., Blagoveshchensk, 675000
I. V. Dovzhikova
Russian Federation
Inna V. Dovzhikova, PhD, DSc. (Biol.), Leading Staff Scientist of Laboratory of Mechanisms of Etiopathogenesis and Recovery Processes of the Respiratory System at Non-Specific Lung Diseases
22 Kalinina Str., Blagoveshchensk, 675000
References
1. Frankevich N., Tokareva A., Chagovets V., Starodubtseva N., Dolgushina N., Shmakov R., Sukhikh G., Frankevich V. COVID-19 infection during pregnancy: disruptions in lipid metabolism and implications for newborn health. Int. J. Mol. Sci. 2023; 24(18):13787. https://doi.org/10.3390/ijms241813787
2. Sobkowski M., Pięta B., Sowińska A., Grabowska M., Koch-Brzozowska K., Wilczak M., Bień A. SARS-CoV-2 in pregnancy – a retrospective analysis of selected maternal and fetal laboratory parameters. Int. J. Environ. Res. Public Health 2022; 19(22):15307. https://doi.org/10.3390/ijerph192215307
3. Vakili S., Savardashtaki A., Jamalnia S., Tabrizi R., Nematollahi M.H., Jafarinia M., Akbari H. Laboratory findings of COVID-19 infection are conflicting in different age groups and pregnant women: a literature review. Arch. Med. Res. 2020; 51(7):603–607. https://doi.org/10.1016/j.arcmed.2020.06.007
4. O'Donnell V.B., Murphy R.C. New families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions. Blood 2012; 120(10):1985–1992. https://doi.org/10.1182/blood-2012-04–402826
5. Mor G., Cardenas I. The immune system in pregnancy: a unique complexity. Am. J. Reprod. Immunol. 2010; 63(6):425–433. https://doi.org/10.1111/j.1600–0897.2010.00836.х
6. Ishutina N.A., Andrievskaya I.A., Sinyakin I.А. [Peculiarities of phospholipiid changes in erythrocyte membranes in parturient women with COVID-19-associated community-acquired pneumonia]. Byulleten' fiziologii i patologii dykhaniya = Bulletin physiology and pathology of respiration 2023; 87:83–89 (in Russian). https://doi.org/10.36604/1998-5029-2023-87-83-89
7. Kaplow L.S. A histochemical procedure for localizing and evaluating leukocyte alkaline phosphatase activity in smears of blood and marrow. Blood 1955; 10(10):1023–1029.
8. Gijón M.A., Leslie C.C. Regulation of arachidonic acid release and cytosolic phospholipase A2 activation. J. Leukoc. Biol. 1999; 65(3):330–336. https://doi.org/10.1002/jlb.65.3.330
9. Andrievskaya I.A., Ustinov E.M., Lyazgian K.S., Ishutina N.A., Dovzhikova I.V. Disruption of the functional activity of neutrophil granulocytes as a risk factor for the development of lung damage in pregnant women with COVID-19. Curr. Iss. Mol. Biology 2024; 46(2):1121–1135. https://doi.org/10.3390/cimb46020071
10. Thomas C.P., O'Donnell V.B. Oxidized phospholipid signaling in immune cells. Curr. Opin. Pharmacol. 2012; 12(4):471–477. https://doi.org/10.1016/j.coph.2012.02.013
11. Leslie C.C. Cytosolic phospholipase A2: physiological function and role in disease. J. Lipid Res. 2015; 56(8):1386–1402. https://doi.org/10.1194/jlr.R057588
12. Hildebrand J., Marique D., Vanhouche J. Lipid composition of plasma membranes from human leukemic lymphocytes. J. Lipid Res. 1975; 16(3):195–199.
13. Gomez-Lopez N., StLouis D., Lehr M.A., Sanchez-Rodriguez E.N., Arenas-Hernandez M. Immune cells in term and preterm labor. Cell. Mol. Immunol. 2014; 11(6):571–581. https://doi.org/10.1038/cmi.2014.46
14. Ishutina N.A., Andrievskaya I.A., Dorofienko N.N. [Changes in lipid composition and serum phospholipids level in women in labor with pneumonia caused by SARS-COV-2]. Byulleten' fiziologii i patologii dykhaniya = Bulletin physiology and pathology of respiration 2023; 90:83–89 (in Russian). https://doi.org/10.36604/1998-5029-2023-90-83-89
Review
For citations:
Kutepova O.L., Andrievskaya I.A., Dovzhikova I.V. Assessment of phospholipid content in blood leukocytes of parturient women who had COVID-19 during the third trimester of pregnancy. Bulletin Physiology and Pathology of Respiration. 2025;(98):139-143. (In Russ.) https://doi.org/10.36604/1998-5029-2025-98-139-143






















